PTCT - PTC Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

PTCT is currently covered by 10 analysts with an average price target of $94.71. This is a potential upside of $20 (40.58%) from yesterday's end of day stock price of $67.37.

PTC Therapeutics's activity chart (see below) currently has 295 price targets and 237 ratings on display. The stock rating distribution of PTCT is 61.9% BUY and 38.1% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 78.93% with an average time for these price targets to be met of 351.91 days.

Highest price target for PTCT is $130, Lowest price target is $55, average price target is $94.71.

Most recent stock forecast was given by ELIANA MERLE from BARCLAYS on 14-Aug-2026. First documented stock forecast 22-Jul-2014.

Currently out of the existing stock ratings of PTCT, 13 are a BUY (61.9%), 8 are a HOLD (38.1%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 14-Aug-2026

$122

$52.7 (76.05%)

$119

28 days ago
(14-Aug-2026)

2/4 (50%)

$50.3 (70.15%)

117

Buy Since 20-Feb-2026

$109

$39.7 (57.29%)

$106

29 days ago
(13-Aug-2026)

1/6 (16.67%)

$37.03 (51.45%)

137

Buy Since 07-Mar-2025

$104

$34.7 (50.07%)

$92

1 months 11 days ago
(31-Jul-2026)

10/13 (76.92%)

$35.99 (52.92%)

189

Buy Since 22-Feb-2023

$130

$60.7 (87.59%)

$118

1 months 26 days ago
(16-Jul-2026)

15/21 (71.43%)

$51.48 (65.56%)

495

Hold Since 20-Feb-2026

$85

$15.7 (22.66%)

$82

2 months 4 days ago
(07-Jul-2026)

39/42 (92.86%)

$-4.2 (-4.71%)

124

Show more analysts

Please expand the browser size to see the chart

What is PTCT (PTC Therapeutics) average time for price targets to be met?

On average it took 352 days for the stock forecasts to be reached, with an average price target met ratio of 78.93%.

Which analyst most recently updated their price target on PTCT (PTC Therapeutics)?

Eliana Merle

Which analyst has the most public recommendations on PTCT (PTC Therapeutics)?

Eliana Merle works at BARCLAYS and has 16 price targets and 13 ratings on PTCT

Which analyst is the currently most bullish on PTCT (PTC Therapeutics)?

Kristen Kluska with the highest potential upside of $60.7

Which analyst is the currently most reserved on PTCT (PTC Therapeutics)?

Simos Simeonidis with the lowest potential downside of -$58.69

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?